Literature DB >> 19726679

mTORbeta splicing isoform promotes cell proliferation and tumorigenesis.

Ganna Panasyuk1, Ivan Nemazanyy, Aleksander Zhyvoloup, Valeriy Filonenko, Derek Davies, Mathew Robson, R Barbara Pedley, Michael Waterfield, Ivan Gout.   

Abstract

The mTOR (mammalian target of rapamycin) promotes growth in response to nutrients and growth factors and is deregulated in numerous pathologies, including cancer. The mechanisms by which mTOR senses and regulates energy metabolism and cell growth are relatively well understood, whereas the molecular events underlining how it mediates survival and proliferation remain to be elucidated. Here, we describe the existence of the mTOR splicing isoform, TOR beta, which, in contrast to the full-length protein (mTOR alpha), has the potential to regulate the G(1) phase of the cell cycle and to stimulate cell proliferation. mTOR beta is an active protein kinase that mediates downstream signaling through complexing with Rictor and Raptor proteins. Remarkably, overexpression of mTOR beta transforms immortal cells and is tumorigenic in nude mice and therefore could be a proto-oncogene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726679      PMCID: PMC2781479          DOI: 10.1074/jbc.M109.056085

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

2.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

3.  Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region.

Authors:  Terunao Takahara; Kenta Hara; Kazuyoshi Yonezawa; Hiroyuki Sorimachi; Tatsuya Maeda
Journal:  J Biol Chem       Date:  2006-07-26       Impact factor: 5.157

4.  RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.

Authors:  P E Burnett; R K Barrow; N A Cohen; S H Snyder; D M Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load.

Authors:  Thomas H Reynolds; Sue C Bodine; John C Lawrence
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

6.  Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin.

Authors:  Xiangyu Liu; X F Steven Zheng
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

Review 7.  Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?

Authors:  M N Corradetti; K-L Guan
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

8.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Authors:  A Sekulić; C C Hudson; J L Homme; P Yin; D M Otterness; L M Karnitz; R T Abraham
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

9.  FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction.

Authors:  Bimal N Desai; Benjamin R Myers; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

10.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene.

Authors:  Rotem Karni; Elisa de Stanchina; Scott W Lowe; Rahul Sinha; David Mu; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2007-02-18       Impact factor: 15.369

View more
  12 in total

1.  Control of mTORC1 signaling by the Opitz syndrome protein MID1.

Authors:  Enbo Liu; Christine A Knutzen; Sybille Krauss; Susann Schweiger; Gary G Chiang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 2.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

Review 3.  Mammalian TOR signaling to the AGC kinases.

Authors:  Bing Su; Estela Jacinto
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-10       Impact factor: 8.250

4.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

5.  Aberrant RNA Splicing in Cancer.

Authors:  Luisa Escobar-Hoyos; Katherine Knorr; Omar Abdel-Wahab
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

6.  HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms.

Authors:  Delphine Planas; Yuwei Zhang; Patricia Monteiro; Jean-Philippe Goulet; Annie Gosselin; Nathalie Grandvaux; Thomas J Hope; Ariberto Fassati; Jean-Pierre Routy; Petronela Ancuta
Journal:  JCI Insight       Date:  2017-08-03

7.  LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.

Authors:  Martin C Herzig; Carine Kolly; Elke Persohn; Diethilde Theil; Tatjana Schweizer; Thomas Hafner; Christine Stemmelen; Thomas J Troxler; Peter Schmid; Simone Danner; Christian R Schnell; Matthias Mueller; Bernd Kinzel; Armelle Grevot; Federico Bolognani; Martina Stirn; Rainer R Kuhn; Klemens Kaupmann; P Herman van der Putten; Giorgio Rovelli; Derya R Shimshek
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 8.  Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer.

Authors:  Zahava Siegfried; Serena Bonomi; Claudia Ghigna; Rotem Karni
Journal:  Int J Cell Biol       Date:  2013-09-03

9.  Small molecule modulation of splicing factor expression is associated with rescue from cellular senescence.

Authors:  Eva Latorre; Vishal C Birar; Angela N Sheerin; J Charles C Jeynes; Amy Hooper; Helen R Dawe; David Melzer; Lynne S Cox; Richard G A Faragher; Elizabeth L Ostler; Lorna W Harries
Journal:  BMC Cell Biol       Date:  2017-10-17       Impact factor: 4.241

10.  Rapamycin response in tumorigenic and non-tumorigenic hepatic cell lines.

Authors:  Rosa H Jimenez; Joan M Boylan; Ju-Seog Lee; Mirko Francesconi; Gastone Castellani; Jennifer A Sanders; Philip A Gruppuso
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.